Author

Annie Lannuzel

Centre National de la Recherche ScientifiqueORCID 0000-0003-4084-8674Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Annekatrin König· 1 shared Antoine DuquetteiD· 1 shared Antonio Dominguez‐MeijideiD· 1 shared Ariane Veilleux CarpentieriD· 1 shared B. TressièresiD· 1 shared Diana F. LázaroiD· 1 shared Eftychia VasiliiD· 1 shared Elaine Aparecida Del BeliD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Annekatrin König

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintMay 4, 2026

Ancestry-specific immune signatures in Parkinson's disease: a rare variant burden analysis in Montreal and Guadeloupe cohorts

Lovatiana Andriamboavonjy, Marjorie Labrecque, Lalla Yasmine Al Idrissi…·Martine Tétreault

This study identifies ancestry-specific immune signatures in Parkinson's disease through rare variant analysis in Montreal and Guadeloupe cohorts, revealing divergent molecular pathways associated with disease.

DOI 10.64898/2026.04.24.26351405

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyNeurobiology of DiseasePeer-reviewedJan 12, 2021

Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo

Antonio Dominguez‐Meijide, Valeria Parrales, Eftychia Vasili…·Tiago F. Outeiro

This study shows doxycycline reduces α-synuclein aggregation and oxidative stress in vitro and in vivo, suggesting it could treat synucleinopathies like Parkinson's disease.

81 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky